bluebird bio, Inc.·4

Feb 6, 4:07 PM ET

Obenshain Andrew 4

4 · bluebird bio, Inc. · Filed Feb 6, 2024

Insider Transaction Report

Form 4
Period: 2024-02-05
Obenshain Andrew
DirectorPresident and CEO
Transactions
  • Sale

    Common Stock

    2024-02-05$0.90/sh1,879$1,696286,093 total
Footnotes (2)
  • [F1]Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
  • [F2]The range in prices for the transaction reported on this line was $0.9011 to $0.9040. The average weighted price was $0.9025. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Documents

2 files